Detalles de la búsqueda
1.
Similar effect of co-administration of methotrexate and folic acid for the treatment of arthritis compared to separate administration.
Rheumatology (Oxford);
62(4): 1706-1710, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36205597
2.
Assessment of the soluble proteins HMGB1, CD40L and CD62P during various platelet preparation processes and the storage of platelet concentrates: The BEST collaborative study.
Transfusion;
63(1): 217-228, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453841
3.
Platelet depletion limits the severity but does not prevent the occurrence of experimental transfusion-related acute lung injury.
Transfusion;
60(4): 713-723, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32108957
4.
Inhibition of the CD40/CD40L complex protects mice against ALI-induced pancreas degradation.
Transfusion;
59(3): 1090-1101, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30784079
5.
Soluble CD40L and CD62P levels differ in single-donor apheresis platelet concentrates and buffy coat-derived pooled platelet concentrates.
Transfusion;
59(1): 16-20, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30291753
6.
Platelet concentrate supernatants alter endothelial cell mRNA and protein expression patterns as a function of storage length.
Transfusion;
58(11): 2635-2644, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30325037
7.
Modeling the effect of platelet concentrate supernatants on endothelial cells: focus on endocan/ESM-1.
Transfusion;
58(2): 439-445, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29238987
8.
Properties of donated red blood cell components from patients with hereditary hemochromatosis.
Transfusion;
57(1): 166-177, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27807848
9.
Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers.
Transfusion;
56(2): 497-504, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26446055
10.
LPS stimulation of purified human platelets is partly dependent on plasma soluble CD14 to secrete their main secreted product, soluble-CD40-Ligand.
BMC Immunol;
16: 3, 2015 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-25636826
11.
Streptococcus sanguinis-induced cytokine and matrix metalloproteinase-1 release from platelets.
BMC Immunol;
15: 15, 2014 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24755160
12.
Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions.
Transfusion;
54(3): 613-25, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23944651
13.
In platelet single donor apheresis, platelet factor 4 levels correlated with donor's age and decreased during storage.
Sci Rep;
14(1): 6231, 2024 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485973
14.
Lipidomic analysis of differently prepared platelet concentrates in additive solution during storage.
Blood Transfus;
21(5): 409-421, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36346879
15.
Bioactive lipids as biomarkers of adverse reactions associated with apheresis platelet concentrate transfusion.
Front Immunol;
14: 1031968, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37138863
16.
The efficacy of therapeutic plasma exchange in COVID-19 patients on endothelial tightness in vitro is hindered by platelet activation.
Front Cardiovasc Med;
10: 1094786, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37215546
17.
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study.
EBioMedicine;
87: 104414, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36535107
18.
Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion.
Clin Immunol;
145(3): 189-200, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23108090
19.
Platelets as Key Factors in Inflammation: Focus on CD40L/CD40.
Front Immunol;
13: 825892, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35185916
20.
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology.
Front Immunol;
13: 1034379, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36275757